Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
3 Biotech ; 11(9): 421, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34603921

ABSTRACT

The whitefly, Bemisia tabaci (Gennadius), is responsible for significant yield losses in many crops, including potato, by sucking the phloem sap and transmitting a number of plant viruses. B. tabaci is a complex of cryptic species which is commonly designated as genetic groups. The B. tabaci genetic groups differ biologically with respect to host plant preference, insecticidal resistance, reproduction capacity, and ability to transmit begomoviruses. Therefore, understanding genetic variation among populations is important for establishing crop-specific distribution profile and management. We sequenced the mitochondrial cytochrome oxidase I (mtCOI) gene of B. tabaci collected from major potato growing areas of India. BLAST analysis of the 24 mtCOI sequences with reference Gene Bank sequences revealed four B. tabaci genetic groups prevailing in this region. mtCOI analysis exhibited the presence of Asia II 1, Asia II 5, Asia 1, and MEAM1 B. tabaci genetic groups. Our study highlighted that a new genetic group Asia II 5 has been detected in Indo-Gangetic Plains. Further virus-vector relationship study of ToLCNDV with Asia II 5 B. tabaci revealed that females are efficient vector of this virus as compared to males. This behavior of females might be due to their ability to acquire more virus titer than males. This study will help in better understanding of whitefly genetic group mediated virus diseases.

2.
Ann Oncol ; 26(1): 40-47, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24997207

ABSTRACT

The tumor antigen (TA)-targeted monoclonal antibodies (mAb) cetuximab and panitumumab target the human epidermal growth factor receptor and have been integrated into treatment regimens for advanced squamous cell carcinoma of the head and neck (SCCHN). The therapeutic efficacy of these mAbs has been found to be enhanced when combined with radiotherapy and chemotherapy. However, clinical trials indicate that these findings are limited to fewer than 20% of treated patients. Therefore, identifying patients who are likely to benefit from these agents is crucial to improving therapeutic strategies. Interestingly, it has been noted that TA-targeted mAbs mediate their effects by contributing to cell-mediated cytotoxicity in addition to inhibition of downstream signaling pathways. Here, we describe the potential immunogenic mechanisms underlying these clinical findings, their role in the varied clinical response and identify the putative biomarkers of antitumor activity. We review potential immunological biomarkers that affect mAb therapy in SCCHN patients, the implications of these findings and how they translate to the clinical scenario, which are critical to improving patient selection and ultimately outcomes for patients undergoing therapy.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , ErbB Receptors/antagonists & inhibitors , Head and Neck Neoplasms/drug therapy , Antigens, Neoplasm/immunology , Biomarkers , Carcinoma, Squamous Cell/radiotherapy , Cetuximab , Combined Modality Therapy , ErbB Receptors/immunology , Head and Neck Neoplasms/radiotherapy , Histocompatibility Antigens Class I/immunology , Humans , Macrophages/immunology , Panitumumab , Papillomavirus Infections , Receptors, IgG/genetics , STAT3 Transcription Factor/immunology , Squamous Cell Carcinoma of Head and Neck , T-Lymphocytes, Regulatory/immunology , Tumor Escape/immunology
3.
Br J Cancer ; 109(10): 2629-35, 2013 Nov 12.
Article in English | MEDLINE | ID: mdl-24169351

ABSTRACT

BACKGROUND: Although regulatory T cells (Treg) are highly enriched in human tumours compared with peripheral blood, expression of the immune-checkpoint receptors, immunosuppressive molecules and function of Treg in these two sites remains undefined. METHODS: Tumour-infiltrating lymphocytes and peripheral blood lymphocytes were isolated from a cohort of head and neck squamous cell carcinoma (HNSCC) patients. The immunosuppressive phenotypes and function of intratumoral Treg were compared with those of peripheral blood Treg. RESULTS: The frequency of immune-checkpoint receptor-positive cells was higher on intratumoral FOXP3(+)CD25(hi) Treg compared with circulating Treg (CTLA-4, P=0.002; TIM-3, P=0.002 and PD-1, P=0.002). Immunosuppressive effector molecules, LAP and ectonucleotidase CD39 were also upregulated on intratumoral FOXP3(+) Treg (P=0.002 and P=0.004, respectively). CTLA-4 and CD39 were co-expressed on the majority of intratumoral FOXP3(+)CD4(+) Treg, suggesting that these molecules have a key role in regulatory functions of these cells in situ. Notably, intratumoral Treg exhibited more potently immunosuppressive activity than circulating Treg. CONCLUSION: These results indicate that intratumoral Treg are more immunosuppressive than circulating Treg and CTLA-4 and CD39 expressed can be potential target molecules to inhibit suppressive activities of intratumoral Treg in situ.


Subject(s)
Carcinoma, Squamous Cell/immunology , Head and Neck Neoplasms/immunology , Immunosuppressive Agents/metabolism , Lymphocytes, Tumor-Infiltrating/immunology , T-Lymphocytes, Regulatory/physiology , Adult , Aged , Aged, 80 and over , Antigens, CD/metabolism , Apyrase/metabolism , CTLA-4 Antigen/metabolism , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/metabolism , Cytokines/metabolism , Female , Head and Neck Neoplasms/blood , Head and Neck Neoplasms/metabolism , Humans , Immune Tolerance/immunology , Lymphocytes, Tumor-Infiltrating/metabolism , Male , Middle Aged , Squamous Cell Carcinoma of Head and Neck , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism
4.
Bioorg Med Chem Lett ; 11(20): 2671-4, 2001 Oct 22.
Article in English | MEDLINE | ID: mdl-11591498

ABSTRACT

A series of substituted N-arylphthalamic acids 3a-i has been synthesized by the reaction of phthalic anhydride 1 and aryl- or heterocyclic amines 2a-i, in the absence of solvents, in a domestic microwave oven. The formation of nine N-arylphthalamic acids was accomplished in 1-3 min giving excellent yields for compounds 3a-g, but moderate yield of compounds 3h and 3i, respectively. Compounds 3h and 3i are new. Interestingly, N-arylphthalamic acids 3a-i induced hyperlipidemia in Swiss white mice and also increased animals' body weight.


Subject(s)
Hypolipidemic Agents/chemical synthesis , Phthalic Acids/chemical synthesis , Animals , Body Weight/drug effects , Hyperlipidemias/chemically induced , Hyperlipidemias/metabolism , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/toxicity , Mice , Microwaves , Models, Animal , Phthalic Acids/chemistry , Phthalic Acids/toxicity
5.
Carbohydr Res ; 332(3): 335-40, 2001 Jun 04.
Article in English | MEDLINE | ID: mdl-11376613

ABSTRACT

A facile synthesis of anomerically pure phthalimidomethyl 2,3,4,6-tetra-O-acetyl- and phthalimidomethyl 2,3-di-O-acetyl-4,6-di-O-benzoyl-alpha-D-mannopyranosides (6 and 9b) starting from N-hydroxymethylphthalimide and tri-O-acetyl-D-glucal is described. Compounds 3, 6, 8, 9a and 9b have been tested for their hypolipidemic activity in mice. All these compound showed significant reduction of plasma cholesterol and triglyceride levels. Compound 9b has been found to possess the highest activity.


Subject(s)
Hypolipidemic Agents/chemical synthesis , Mannosides/pharmacology , Animals , Cholesterol/blood , Hypolipidemic Agents/pharmacology , Male , Mannosides/chemical synthesis , Mice , Phthalimides/chemical synthesis , Phthalimides/pharmacology , Triglycerides/blood
7.
Farmaco ; 55(11-12): 719-24, 2000.
Article in English | MEDLINE | ID: mdl-11204948

ABSTRACT

A new series of 1,2,4-oxadizoles 6a-g have been synthesised in good yields using the peptide synthesis strategy. The prepared compounds were tested for anti-inflammatory and antimicrobial activities. The anti-inflammatory activities were determined in the rat paw oedema induced by carrageenin. Compounds 6a, c, f and g (i.v.) significantly inhibited the rat paw oedema induced by carrageenin depending upon the dose employed. The compounds were also evaluated for their in vitro antimicrobial activity. Some compounds were found to have significant activity against Gram positive and Gram negative microorganisms.


Subject(s)
Anti-Infective Agents/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Oxadiazoles/chemistry , Animals , Anti-Bacterial Agents , Bacteria/drug effects , Carrageenan , Edema/chemically induced , Edema/prevention & control , Fungi/drug effects , Male , Microbial Sensitivity Tests , Oxadiazoles/pharmacology , Rats , Rats, Wistar
8.
Bioorg Med Chem Lett ; 8(21): 3071-6, 1998 Nov 03.
Article in English | MEDLINE | ID: mdl-9873678

ABSTRACT

Seven new phthalimide derivatives (9a-g) with 1,2,4-oxadiazol-5-yl methyl group attached to nitrogen have been synthesized from N-phthaloylglycine 6 and arylamidoximes 7a-g. All of these showed potent analgesic effect with acetic acid induced "writhing" test in mice. One of the better compounds (ID50 = 2.2 mg/Kg i.p.) has been found to be 9a which also demonstrates analgesic activity against inflammatory pain.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Phthalimides/chemical synthesis , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Mice , Phthalimides/pharmacology
9.
Braz J Med Biol Res ; 27(6): 1403-6, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7894354

ABSTRACT

Significant local analgesic and anti-inflammatory activity has been observed after oral administration of 3-[3-(phenyl)-1,2,4-oxadiazol-5-yl] propionic acid (POPA). Doses of 150 and 300 mg/kg body weight administered orally by gavage to adult (25-35 g) albino mice of both sexes can inhibit acetic acid-induced writhing by 31.0% and 49.5%, respectively (mean +/- SEM writhing numbers during 20 min were 52.0 +/- 6.0 and 38.3 +/- 7.2 vs 75.8 +/- 6.6 for control group which received saline; N = 6). Carrageenin-induced inflammation in the female Wistar rat (200-250 g) can be reduced by 43.3% and 42.2% 3 h after oral administration (gavage) of 75 and 150 mg/kg of POPA (mean +/- SEM, 30.0 +/- 1.3% and 30.6 +/- 2.4% vs 52.9 +/- 3.7% for control group which received saline; N = 5). In the hot plate test on adult albino mice (25-35 g) of both sexes, POPA (150 and 300 mg/kg, po) was totally ineffective (N = 10). Our results indicate that POPA appears to offer potential safety and efficacy as a local analgesic and anti-inflammatory agent with no central nervous system involvement


Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Inflammation/drug therapy , Oxadiazoles/therapeutic use , Pain/drug therapy , Administration, Oral , Animals , Anti-Inflammatory Agents , Female , Male , Mice , Rats , Rats, Wistar , Time Factors
10.
Braz. j. med. biol. res ; 27(6): 1403-1406, June 1994.
Article in English | LILACS | ID: lil-319762

ABSTRACT

Significant local analgesic and anti-inflammatory activity has been observed after oral administration of 3-[3-(phenyl)-1,2,4-oxadiazol-5-yl] propionic acid (POPA). Doses of 150 and 300 mg/kg body weight administered orally by gavage to adult (25-35 g) albino mice of both sexes can inhibit acetic acid-induced writhing by 31.0 and 49.5, respectively (mean +/- SEM writhing numbers during 20 min were 52.0 +/- 6.0 and 38.3 +/- 7.2 vs 75.8 +/- 6.6 for control group which received saline; N = 6). Carrageenin-induced inflammation in the female Wistar rat (200-250 g) can be reduced by 43.3 and 42.2 3 h after oral administration (gavage) of 75 and 150 mg/kg of POPA (mean +/- SEM, 30.0 +/- 1.3 and 30.6 +/- 2.4 vs 52.9 +/- 3.7 for control group which received saline; N = 5). In the hot plate test on adult albino mice (25-35 g) of both sexes, POPA (150 and 300 mg/kg, po) was totally ineffective (N = 10). Our results indicate that POPA appears to offer potential safety and efficacy as a local analgesic and anti-inflammatory agent with no central nervous system involvement


Subject(s)
Animals , Male , Female , Mice , Rats , Analgesics/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal , Inflammation/drug therapy , Oxadiazoles/therapeutic use , Pain , Administration, Oral , Anti-Inflammatory Agents , Rats, Wistar , Time Factors
11.
Carbohydr Res ; 136: 91-9, 1985 Feb 28.
Article in English | MEDLINE | ID: mdl-4005893

ABSTRACT

The Diels-Alder product from the reaction of methyl 2,3,6-trideoxy-alpha-D-glycero-hex-2-enopyranosid-4-ulose (1b) with trans-1-methoxy-3-tert-butyl-dimethylsilyloxy-1,3-butadiene is 3b (93%). Reaction of 3b wih sodium borohydride causes reduction of the C-4 carbonyl group only, but, with lithium aluminum hydride, further reactions occur which can be rationalized by fragmentation brought about by hydride cleavage on the silicon-oxygen bond, with simultaneous ejection of the beta-methoxyl group complexed to a trivalent aluminum species. The enone resulting from this fragmentation also reacts further with lithium aluminum hydride, and several products result. The behavior of postulated intermediates, which have been prepared separately and subjected to the reaction conditions, supports the proposed reaction mechanisms. The "second generation" enone (methyl 2,3,6-trideoxy-alpha-D-talopyranosido)-[3,2-d]-2-cyclohexenone+ ++ (10a), arising from the first generation precursors 1b, has been prepare by two routes.


Subject(s)
Methylglycosides , Chemical Phenomena , Chemistry , Hydrogen-Ion Concentration , Magnetic Resonance Spectroscopy , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...